Author

Anthony Doyle

Observed names: A G Doyle, Anthony G Doyle, Anthony G. Doyle, Anthony Gerard Doyle

Institution: Teva Pharmaceuticals (Australia)

Observed institutions: The University of Queensland, QIMR Berghofer Medical Research Institute, University of Oxford, Teva Pharmaceuticals (Australia)

OpenAlex ID: A5024592934

Interleukin‐13 alters the activation state of murine macrophages in vitro: Comparison with interleukin‐4 and interferon‐γ

1994 · Anthony G. Doyle, Georges Herbein, et al. · European Journal of Immunology · 321

Macrophage-colony-stimulating factor selectively enhances macrophage scavenger receptor expression and function.

1994 · W J de Villiers, I P Fraser, et al. · The Journal of Experimental Medicine · 128

PDF

Molecular immunobiology of macrophages: recent progress

1995 · Siamon Gordon, Sandra Clarke, et al. · Current Opinion in Immunology · 120

Interleukin 13 inhibits human immunodeficiency virus type 1 production in primary blood-derived human macrophages in vitro.

1993 · L J Montaner, A G Doyle, et al. · The Journal of Experimental Medicine · 102

PDF

Single-cell analysis by RT-PCR reveals differential expression of multiple type 1 and 2 cytokine genes among cells within polarized CD4+ T cell populations

1999 · Anne Kelso, Penny Groves, et al. · International Immunology · 59

An anti-TL1A antibody for the treatment of asthma and inflammatory bowel disease

2018 · Adam W. Clarke, Lynn Poulton, et al. · mAbs · 57

PDF

Targeting Attenuated Interferon-α to Myeloma Cells with a CD38 Antibody Induces Potent Tumor Regression with Reduced Off-Target Activity

2016 · Sarah L. Pogue, Tetsuya Taura, et al. · PLoS ONE · 57

PDF

Lipopolysaccharide (LPS) down-regulates CD4 expression in primary human macrophages through induction of endogenous tumour necrosis factor (TNF) and IL-1β

1995 · G Herbein, A G Doyle, et al. · Clinical & Experimental Immunology · 44

The Activated Type 1–Polarized Cd8+ T Cell Population Isolated from an Effector Site Contains Cells with Flexible Cytokine Profiles

1999 · Anthony G. Doyle, Kathy Buttigieg, et al. · The Journal of Experimental Medicine · 33

PDF

Anti-TNFα domain antibody construct CEP-37247

2010 · Robert D. Gay, Adam W. Clarke, et al. · mAbs · 28

Effect of recombinant human macrophage colony-stimulating factor 1 on immunopathology of experimental brucellosis in mice

1992 · A G Doyle, W J Halliday, et al. · Infection and Immunity · 28

Higher Binding Affinity and In Vitro Potency of Reslizumab for Interleukin-5 Compared With Mepolizumab

2019 · Mark Liddament, Jean Husten, et al. · Allergy Asthma and Immunology Research · 24

PDF

Beneficial Effects of Human Anti-Interleukin-15 Antibody in Gluten-Sensitive Rhesus Macaques with Celiac Disease

2018 · Karol Sestak, Jason P. Dufour, et al. · Frontiers in Immunology · 22

PDF

Potent neutralizing anti-CD1d antibody reduces lung cytokine release in primate asthma model

2015 · Jonathan Nambiar, Adam W Clarke, et al. · mAbs · 16

PDF

Supplementation of Reduced Gluten Barley Diet with Oral Prolyl Endopeptidase Effectively Abrogates Enteropathy-Associated Changes in Gluten-Sensitive Macaques

2016 · Karol Sestak, Hazel Thwin, et al. · Nutrients · 15

PDF

A novel class of anti-IL-12p40 antibodies

2010 · Adam W. Clarke, Lynn Poulton, et al. · mAbs · 14

Use of surface molecules and receptors for studying macrophages and mononuclear phagocytes

1994 · Iain Fraser, Anthony Doyle, et al. · Journal of Immunological Methods · 14

Assays for macrophage activation by cytokines

1995 · Anthony Doyle, Michael Stein, et al. · Oxford University Press eBooks · 3

800 Preclinical in vivo characterization of the anti-tumor activity of a non-blocking PD-1 antibody fused to attenuated IL-2

2024 · Ortal Iancu Cohen, Safra Rudnick-Glick, et al. · Journal for ImmunoTherapy of Cancer · 2

ID: 17

2015 · Sarah Pogue, Tetsuya Taura, et al. · Cytokine

Abstract A13: Anti-CD38-attenukine: A myeloma-targeting immunocytokine containing an engineered IFNα that provides >10,000-fold enhanced tumor-specific activity compared to native IFNα.

2015 · Sarah Pogue, Tetsuya Taura, et al. · Clinical Cancer Research

Abstract 2660: Targeting an attenuated cytokine to tumor cells via antibody fusion results in enhanced tumor killing with significantly reduced off-target activity

2014 · Sarah L. Pogue, Tetsuya Taura, et al. · Cancer Research

Assays for macrophage activation by cytokines

2000 · Anthony Doyle, Michael Stein, et al. · Oxford University Press eBooks

Immunosuppression in experimental brucellosis

1991 · Anthony Gerard Doyle · The University of Queensland

Works count: 24

Citation count: 1,087

H-index: 15

I10-index: 17